Our top pick for
Citizens, Inc is an insurance-life business based in the US. Citizens shares (CIA) are listed on the NYSE and all prices are listed in US Dollars.
|52-week range||USD$3.55 - USD$6.7|
|50-day moving average||USD$6.0203|
|200-day moving average||USD$5.956|
|Wall St. target price||USD$7|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.047|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Citizens stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Citizens's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Citizens's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 118x. In other words, Citizens shares trade at around 118x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Citizens's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$6.5 million.
The EBITDA is a measure of a Citizens's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$243.7 million|
|Gross profit TTM||USD$55.7 million|
|Return on assets TTM||-0.18%|
|Return on equity TTM||-2.72%|
|Market capitalisation||USD$310.7 million|
TTM: trailing 12 months
There are currently 6.6 million Citizens shares held short by investors – that's known as Citizens's "short interest". This figure is 1.1% down from 6.7 million last month.
There are a few different ways that this level of interest in shorting Citizens shares can be evaluated.
Citizens's "short interest ratio" (SIR) is the quantity of Citizens shares currently shorted divided by the average quantity of Citizens shares traded daily (recently around 82724.017957351). Citizens's SIR currently stands at 80.19. In other words for every 100,000 Citizens shares traded daily on the market, roughly 80190 shares are currently held short.
However Citizens's short interest can also be evaluated against the total number of Citizens shares, or, against the total number of tradable Citizens shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Citizens's short interest could be expressed as 0.13% of the outstanding shares (for every 100,000 Citizens shares in existence, roughly 130 shares are currently held short) or 0.1346% of the tradable shares (for every 100,000 tradable Citizens shares, roughly 135 shares are currently held short).
A SIR above 20% would generally be considered very high, pointing to a pessimistic outlook for the share price, with a discouraging number of investors currently willing to bet against Citizens.
Find out more about how you can short Citizens stock.
We're not expecting Citizens to pay a dividend over the next 12 months.
Citizens's shares were split on a 107:100 basis on 13 December 2005. So if you had owned 100 shares the day before before the split, the next day you'd have owned 107 shares. This wouldn't directly have changed the overall worth of your Citizens shares – just the quantity. However, indirectly, the new 6.5% lower share price could have impacted the market appetite for Citizens shares which in turn could have impacted Citizens's share price.
Over the last 12 months, Citizens's shares have ranged in value from as little as $3.55 up to $6.7. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Citizens's is 0.2503. This would suggest that Citizens's shares are less volatile than average (for this exchange).
Citizens, Inc., through its subsidiaries, provides life insurance products in the United States and internationally. It operates in two segments, Life Insurance and Home Service Insurance. The Life Insurance segment issues ordinary whole life insurance and endowment policies in the United States dollar-denominated amounts to foreign residents in approximately 20 countries through 1,000 independent marketing consultants, as well as through independent marketing firms and consultants throughout the United States. It also provides health insurance policies. The Home Service Insurance segment offers pre-need and final expense ordinary life insurance, and annuities to middle and lower income individuals primarily in Louisiana, Mississippi, and Arkansas. It provides its products and services through funeral homes and independent agents, as well as through a home service marketing distribution system. The company was founded in 1969 and is headquartered in Austin, Texas.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.